[Register Now!] JAGntd-GHIT NTD webinar series: Challenges of expanding access to health products in the fight against NTDs
Neglected tropical diseases (NTDs) prevail among the hard-to-reach populations in the world. To protect them from NTDs, developing good health products is necessary, but is not sufficient without creating access to them. Access is a complex matter: no single organization can create it successfully. This webinar series will clarify some conceptual aspects about access, discuss key access challenges from different perspectives and how these can be overcome. The webinar series also considers how Japanese actors might be able to contribute to addressing some of those access challenges.
[Language] English. Simultaneous translation into Japanese will be provided.
[Organizer] Japan Alliance on Global Neglected Tropical Diseases (JAGntd)
[Sponsor] GHIT Fund
Session 1: Concepts and definitions: What is access?
Session 1 will clarify conceptual fogs around access. The term “access” is widely used, but often without a clear definition. The lecture by Prof. Reich will introduce an “access framework” that defines access and its related terms. As an example of using the access framework, Dr. Yoshioka (JAGntd) will present his study about access to Chagas disease treatment in the United States. The concepts and definitions introduced in Session 1 will be used throughout the webinar series.
[Date/Time] Monday, September 13th, 2021, 10:00-11:00 am JST
[Invited speaker] Prof. Michael Reich, Harvard Chan School of Public Health
・Dr. Kota Yoshioka (Deputy Director, JAGntd)
・Dr. Isaac T. Chikwanha (Senior Director, Investment Strategy, Access & Delivery, GHIT Fund)
・Session 2: "Developer's Perspective: About Fexinidazole, a Treatment for African Trypanosomiasis (African Sleeping Sickness)" October 2021
・Session 3: "Country's Perspective: Introduction of Pediatric Praziquantel for Schistosomiasis in Tanzania" November 2021
・Session 4: "WHO's Perspective: Strengthening National NTD Programs in Africa" December 2021
・Session 5: "Nudging the Industry (1): Visualizing Pharmaceutical Companies' Efforts" January 2022
・Session 6: "Nudging the Industry (2): Patent as a Barrier or Leverage?" February 2022
・Session 7: "Financing: Who Pays for What?" March 2022